Cortechs.ai and Subtle Medical have agreed to integrate the NeuroQuant portfolio for automated brain volumetry and lesion quantification with Subtle Medical's AI-based MRI acceleration and image enhancement tools. The combination is intended to produce quantitative neuroimaging measures from shorter, lower-resolution acquisitions without compromising measurement reliability. Serial volumetric assessment of brain structures underpins the detection of neurodegenerative change years before clinical presentation.
Key Points
- NeuroQuant volumetry integrated with Subtle Medical AI image enhancement and alignment
- Shorter MRI acquisitions targeted without loss of quantitative measurement reliability
- Automated lesion and atrophy quantification supports earlier neurodegeneration detection
Longevity Analysis
Brain volume loss is among the most quantifiable markers of biological aging in the central nervous system, yet serial MRI remains constrained by scan duration, cost, and limited scanner capacity. Reducing acquisition time while preserving volumetric accuracy makes repeated structural assessment practical as a surveillance tool rather than a diagnostic endpoint, allowing hippocampal and cortical trajectories to be tracked against normative data over years. Cognitive longevity programs depend on this kind of objective, repeatable measurement to distinguish genuine structural change from normal variation.
Original published by LT Wire.